正海生物：10月23日召开董事会会议

Group 1 - The company Zhenghai Biological announced that its fourth board meeting was held on October 23, 2025, via communication, where the agenda included the review of the third quarter report for 2025 [1] - For the year 2024, the company's revenue composition is 100% from medical devices [1] - As of the report, Zhenghai Biological has a market capitalization of 3.6 billion yuan [1] Group 2 - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year [1] - The secondary market for biomedicine is thriving, while the primary market is facing challenges in fundraising [1]